Yang Li1,2, Yinan Ding1,2, Jinghao Wang3

  • 1Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Frontiers in immunology
|December 11, 2024
PubMed
概括

肝细胞癌 (HCC) 在分子层面上被分为四个亚型,指导精密医学. 一种亚型对抗PD1治疗有前途,而FTCD是特定HCC亚型的潜在治疗标.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K